Enhanced antiviral therapy methods and devices
AssigneeAethlon Medical, Inc.
InventorsRichard H Tullis, Harold H. Handley, JR., Paul R. Duffin, James A. Joyce
Life of this patent
Estimating the term…
Abstract
Embodiments of the present invention relate to enhanced antiviral therapy methods, devices, and kits for treating viral infections. The disclosed enhanced antiviral therapy methods, devices, and kits enhance the efficacy of an antiviral therapy by administering a lectin affinity hemodialysis treatment to an individual suffering from viral infection in combination with the antiviral therapy.
Claims21
1-53. (canceled)
An enhanced antiviral therapy method for treating an individual suffering from viral infection, the method comprising:
- administering to said individual a course of antiviral therapy;
- and
- enhancing the efficacy of said antiviral therapy by administering a lectin affinity hemodialysis treatment to said individual, wherein said lectin affinity hemodialysis treatment comprises passing blood or plasma from said individual through a lectin affinity hemodialysis device, wherein a lectin in said lectin affinity hemodialysis device binds a virus or fragments thereof in said blood or plasma, and wherein said lectin traps said virus or fragments thereof in said lectin affinity hemodialysis device, removing said virus or fragments thereof from said blood or plasma.
A kit for treating an individual suffering from viral infection, the kit comprising:
- a lectin affinity hemodialysis device;
- and
- at least one antiviral agent.
An enhanced lectin affinity hemodialysis therapy method for treating an individual suffering from viral infection, the method comprising:
- administering a course of lectin affinity hemodialysis therapy to said individual, wherein said lectin affinity hemodialysis therapy comprises passing blood or plasma from said individual through a lectin affinity hemodialysis device, wherein a lectin in said lectin affinity hemodialysis device binds a virus or fragments thereof in said blood or plasma, and wherein said lectin traps said virus or fragments thereof in said lectin affinity hemodialysis device, removing said virus or fragments thereof from said blood or plasma;
- and
- enhancing the efficacy of said course of lectin affinity hemodialysis therapy by administering to said individual a course of antiviral therapy during the course of said hemodialysis treatment.
Dependencies are inferred from the claim text.